Mustang Bio, Inc. (MBIO) Financials

MBIO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 15.6 million 8.1 million
March 31, 2026 16.6 million 8.0 million
Dec. 31, 2025 17.6 million 8.1 million
Sept. 30, 2025 19.4 million 9.6 million

MBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -967000 21000
March 31, 2026 -1.0 million 22000
Dec. 31, 2025 -1.7 million 23000
Sept. 30, 2025 -818000 23000

MBIO Net Income

No data available :(

MBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 15.2 million - -
March 31, 2026 16.3 million - -
Dec. 31, 2025 17.3 million - -
Sept. 30, 2025 19.0 million - -

MBIO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 6.7 million
March 31, 2026 6.7 million
Dec. 31, 2025 7.3 million
Sept. 30, 2025 6.2 million

MBIO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 224000 946000 -
March 31, 2026 - 178000 880000 -
Dec. 31, 2025 - -317000 987000 -
Sept. 30, 2025 - 333000 957000 -

MBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -

MBIO

Price: $0.51

52 week price:
0.51
1.85

Earnings Per Share: -0.42 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 169948

Ebitda: -6.9 million

Market Capitalization: 4.1 million

Links: